trending Market Intelligence /marketintelligence/en/news-insights/trending/K0T8DrEpnzYx_WGaumEAiw2 content esgSubNav
In This List

Neos Therapeutics plans common stock offering

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Neos Therapeutics plans common stock offering

Neos Therapeutics Inc. initiated an underwritten public offering of its common shares.

Neos plans to grant underwriters the option to purchase up to an additional 15% of the number of common shares sold in the offering.

Cowen and Co. and BMO Capital Markets are acting as joint book-running managers for the offering.